SCHEMBL16612964

SCHEMBL16612964

CN(C)c1cccc(-c2ocnc2OC(=O)O)c1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.44
HCRTR2 O43614 1/20 0.40
FFAR1 O14842 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
FYN P06241 4/20 0.37
ADORA2A P29274 1/20 0.37
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
LRRK2 Q5S007 1/20 0.36
IP6K1 Q92551 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
AURKA O14965 1/20 0.34
MAPT P10636 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27817797 0.90 NOTUM (0.44) NOTUMHCRTR2FFAR1BCHEACHE
SCHEMBL15189624 0.83 MEN1 (0.46) HCRTR2ADORA2AIP6K1KDM4EALDH1A1
SCHEMBL16612946 0.82 ADORA2A (0.44) ADORA2AIP6K1KDM4EALDH1A1
SCHEMBL15189706 0.81 GSK3B (0.51) NOTUMKDM4EALDH1A1MAPTSMN1; SMN2
SCHEMBL5546097 0.80 ADORA2A (0.54) HCRTR2ADORA2AKDM4EALDH1A1MAPT
SCHEMBL1166732 0.80 ADORA2A (0.49) NOTUMHCRTR2FYNADORA2ALRRK2
SCHEMBL16612795 0.80 KDM4E (0.43) NOTUMHCRTR2FFAR1ADORA2AKDM4E
SCHEMBL16613030 0.80 KMO (0.42) NOTUMHCRTR2FFAR1ADORA2AKDM4E
SCHEMBL16612913 0.78 NOTUM (0.45) NOTUMHCRTR2ADORA2A
SCHEMBL17746044 0.78 GSK3B (0.34) ADORA2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440555-B1 FLUORINATED AMINOTRIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2016-05-18 EP claimed
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP claimed